8 minutes | Apr 2nd 2020

Research could lead to new therapeutic options for lymphedema patients

Thanks to a somewhat unexpected research journey, Tamara Terzian, PhD, and her team recently uncovered a new molecular pathway to a previously untreatable and common lymphatic disease, lymphedema. Terzian also shares thoughts on the COVID-19 pandemic’s impact on her native France.
Play
Like
Play Next
Mark
Played
Share